Immune-Modifying Framework
The Immune-Modifying Framework is a clinical approach for couples with repeated pregnancy loss or unexplained implantation failure. Some RRM practices use it. The framework looks for immune system problems. It then addresses them as part of the evaluation for the cause.
The framework is most fully built out in the clinical approach of NeoFertility.1 Other named methods also use related immune tests. The framework rests on one idea. Abnormal immune activity where the embryo implants can contribute to pregnancy failure. This contributor can be diagnosed. The loss does not have to be dismissed as idiopathic, meaning without a known cause.23
Immune factors that may be checked include antiphospholipid syndrome. The activity of natural killer cells in the uterus is another. Autoimmune thyroid disease is a third. Others are inherited or acquired thrombophilia, a tendency to form clots, and chronic endometritis.456 Clinicians do not run these tests as one standard panel for every couple.
The framework is tailored to each couple. The choice of tests depends on the history of the couple and how past pregnancies ended. It also depends on the named method the practice follows.2 Testing and treatment in this area need direct oversight by a physician. The approach cannot be made the same across all restorative practices.
The framework reflects a broader principle in restorative care. Recurrent pregnancy loss and implantation failure deserve a search for the cause, not an empiric bypass that proceeds without one.4 ART protocols respond to implantation failure by changing the conditions for embryo transfer or by adding more cycles. This framework asks a different question. Does the body have a condition that can be corrected? That contrast is central to the corrective-vs-bypass distinction.
The strength of evidence for each treatment varies widely across these immune factors. The OPTIMUM treatment strategy from Japan is one structured plan. It combines several treatments for overlapping immune and clotting problems.7 Couples with confirmed immune factors benefit most from a specific type of evaluation. That evaluation comes from a clinician trained in a named method that formally uses this framework.
Cited in this entry
- NeoFertility. https://neofertility.ie/
- ESHRE guideline: recurrent pregnancy loss. https://pmc.ncbi.nlm.nih.gov/articles/PMC6276652/
- Lash GE, Robson SC, Bulmer JN. Functional role of uNK cells in human early pregnancy decidua. Placenta. 2010;31 Suppl:S87-92. https://pubmed.ncbi.nlm.nih.gov/20061017/
- Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure. https://pubmed.ncbi.nlm.nih.gov/26456229/
- Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome. https://pmc.ncbi.nlm.nih.gov/articles/PMC8252114/
- Moreno I, Codoñer FM, Vilella F, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703. https://pubmed.ncbi.nlm.nih.gov/27717732/
- Kuroda K, Ikemoto Y, Horikawa T, et al. Novel approaches to the management of recurrent pregnancy loss: The OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy. https://rrmacademy.org/library/novel-approaches-to-the-management-of-recurrent-pregnancy-loss-the-optimum-optim-recotwemmxon5hm20/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.

